Barclays Upgrades Evolus to Overweight, Raises Price Target to $16
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Balaji Prasad upgraded Evolus (NASDAQ:EOLS) from Equal-Weight to Overweight and increased the price target from $10 to $16, indicating a positive outlook on the company's stock.
January 29, 2024 | 10:23 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evolus received an upgrade from Barclays analyst Balaji Prasad, changing its rating from Equal-Weight to Overweight with a raised price target from $10 to $16.
The upgrade by Barclays reflects a positive change in the analyst's view of Evolus's prospects, likely due to improved fundamentals or market position. The substantial increase in the price target suggests that Barclays sees significant upside potential for the stock. This kind of analyst action can often lead to a short-term increase in stock price as it may influence investor sentiment and lead to increased buying pressure.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100